VA/DOD Clinical Practice Guideline for Management of Type 2 Diabetes Mellitus in Primary Care Guideline Summary
Editat de Veterans Affairs Dept. (U.S.), Defense Dept. Autor VA/DOD Evidence-Based Practice Guideline Work Group (U.S.)en Limba Engleză Paperback – 23 aug 2017 – vârsta ani
The
guideline
describes
the
critical
decision
points
in
the
Management
of
Diabetes
Mellitus
(DM)
and
provides
clear
and
comprehensive
evidence
based
recommendations
incorporating
current
information
and
practices
for
practitioners
throughout
the
DoD
and
VA
Health
Care
systems.
The
guideline
is
intended
to
improve
patient
outcomes
and
local
management
of
patients
with
diabetes
mellitus.
(This Clinical Practice Guideline is intended for use only as a tool to assist a clinician/healthcare professional and should not be used to replace clinical judgment.)
Related items:
Physician References & Medical Handbookscan be found here: https://bookstore.gpo.gov/catalog/physician-references-medical-handbooks
Diabetes & Obesity publicationscan be found here: https://bookstore.gpo.gov/catalog/diabetes-obesity
Other products produced by theU.S. Department of Veterans Affairs (VA)are available here: https://bookstore.gpo.gov/agency/department-veterans-affairs-va
(This Clinical Practice Guideline is intended for use only as a tool to assist a clinician/healthcare professional and should not be used to replace clinical judgment.)
Related items:
Physician References & Medical Handbookscan be found here: https://bookstore.gpo.gov/catalog/physician-references-medical-handbooks
Diabetes & Obesity publicationscan be found here: https://bookstore.gpo.gov/catalog/diabetes-obesity
Other products produced by theU.S. Department of Veterans Affairs (VA)are available here: https://bookstore.gpo.gov/agency/department-veterans-affairs-va
Preț: 86.28 lei
Nou
Puncte Express: 129
Preț estimativ în valută:
16.52€ • 17.17$ • 13.69£
16.52€ • 17.17$ • 13.69£
Carte indisponibilă temporar
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780160941337
ISBN-10: 0160941334
Pagini: 28
Ilustrații: grsphs
Dimensiuni: 216 x 279 mm
Ediția:fifth edition, Version 5.0
Editura: United States Dept. of Veterans Affairs
Colecția United States Department of Veterans Affairs
ISBN-10: 0160941334
Pagini: 28
Ilustrații: grsphs
Dimensiuni: 216 x 279 mm
Ediția:fifth edition, Version 5.0
Editura: United States Dept. of Veterans Affairs
Colecția United States Department of Veterans Affairs
Notă biografică
ABOUT
THE
AUTHOR/AGENCY:
TheVA/DoD Evidence-Based Practice Guideline Work Group(EBPWG) was established to advise the VA/DoD Health Executive Council (HEC) on the use of clinical and epidemiological evidence to improve the health of the population across the Veterans Health Administration (VHA) and Military Health System. TheEBPWGhas two co-chairpersons (one from VA and one from DoD) and include representatives for each military branch and the VHA Veterans Integrated Service Networks (VISN). The workgroup was first chartered in 2004.
TheVA/DoD Evidence-Based Practice Guideline Work Group(EBPWG) was established to advise the VA/DoD Health Executive Council (HEC) on the use of clinical and epidemiological evidence to improve the health of the population across the Veterans Health Administration (VHA) and Military Health System. TheEBPWGhas two co-chairpersons (one from VA and one from DoD) and include representatives for each military branch and the VHA Veterans Integrated Service Networks (VISN). The workgroup was first chartered in 2004.
Cuprins
Table
of
Contents
for
Clinician
Summary:
I. Introduction .................................................................................................................................. 3
II. Background................................................................................................................................... 3
A. Description of Diabetes Mellitus...................................................................................................... 3
B. Epidemiology and Impact................................................................................................................. 5
III. Scope of this CPG........................................................................................................................... 6
IV. Shared Decision-making and Patient-centered Care ...................................................................... 6
V. Guideline Work Group................................................................................................................... 8
VI. Algorithm...................................................................................................................................... 9
A. Module A: General Care and Treatment........................................................................................10
B. Module B: Diabetes Self-Management Education ........................................................................11
VII. Recommendations ...................................................................................................................... 12
VIII. Glycemic Control Targets and Monitoring.................................................................................... 14
IX. Pharmacological Therapy ............................................................................................................ 15
X. Methods...................................................................................................................................... 29
A. Strength of Recommendations ......................................................................................................29
B. Recommendation Categorization...................................................................................................31
References ........................................................................................................................................ 33
I. Introduction .................................................................................................................................. 3
II. Background................................................................................................................................... 3
A. Description of Diabetes Mellitus...................................................................................................... 3
B. Epidemiology and Impact................................................................................................................. 5
III. Scope of this CPG........................................................................................................................... 6
IV. Shared Decision-making and Patient-centered Care ...................................................................... 6
V. Guideline Work Group................................................................................................................... 8
VI. Algorithm...................................................................................................................................... 9
A. Module A: General Care and Treatment........................................................................................10
B. Module B: Diabetes Self-Management Education ........................................................................11
VII. Recommendations ...................................................................................................................... 12
VIII. Glycemic Control Targets and Monitoring.................................................................................... 14
IX. Pharmacological Therapy ............................................................................................................ 15
X. Methods...................................................................................................................................... 29
A. Strength of Recommendations ......................................................................................................29
B. Recommendation Categorization...................................................................................................31
References ........................................................................................................................................ 33